# Paul W. Wallace, MD – FDA Inspection, Mar 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/paul-w-wallace-md/f6ed70f6-0bc5-4521-9c11-8fcd6786192e
Source feed: FDA_Inspections

> FDA inspection 1307736 of Paul W. Wallace, MD, March 17, 2026. 1 citation under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1307736
- Company Name: Paul W. Wallace, MD
- Inspection Date: 2026-03-17
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1208694 - 2023-06-16
- [FDA Inspection 1055969 - 2018-06-08](https://www.keypedia.com/records/fda_inspections/paul-w-wallace-md/3527f127-26e3-41e1-9e59-f8fa618a9260)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/bruno-baltazar/95a94f09-6e24-4454-a18d-4cef89e721d9)
- [Issuing Officer](https://www.keypedia.com/people/jasmine-y-wang/e23c7335-477c-4671-8dcc-72e9149d424e)

Company: https://www.keypedia.com/companies/paul-w-wallace-md/c6e736a3-93ff-4b83-aa9d-86fb904877ca

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
